CRISPR/sgRNA-SAM therapy: a potential breakthrough for Parkinson’s disease?

Researchers utilize the CRISPR-Cas9 system to induce the synthesis of dopamine (DA) in the brains of a rat model for Parkinson’s disease.

AC-0676 by Accutar Biotechnology for Follicular Lymphoma: Likelihood of Approval

GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes

July 8, 2023

WuXi Biologics execs register to lobby as Congress comes for the company

WASHINGTON — WuXi Biologics executives have joined the lobbying fray in the lead-up to a move by Congress to add the company to a blacklist

May 15, 2024

‘Critically Impactful’ Drug Shortages; Emotions and Cancer; CRC Clues in Microbiome

In a recent survey, almost a third of healthcare system pharmacists said drug shortages are “critically impacting” patient care. (CNN) Six months of aerobic exercise

August 11, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.